Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25053 | 22210573 | Diabetes Care | Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. | 2011 | Details |
| A25055 | 22209679 | Clin Nutr | Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes. | 2011 | Details |
| A25061 | 24713801 | Ann Gastroenterol | Non-alcoholic fatty liver disease may develop in individuals with normal body mass index. | 2012 | Details |
| A25089 | 22182015 | Scand J Gastroenterol | Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. | 2011 | Details |
| A25092 | 22180989 | Bratisl Lek Listy | Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes? | 2011 | Details |
| A25097 | 22173246 | Singapore Med J | Metabolic syndrome. | 2011 | Details |
| A25117 | 22156706 | QJM | Prevalence and markers of advanced liver disease in type 2 diabetes. | 2011 | Details |
| A25118 | 22155853 | Hepatogastroenterology | Non-alcoholic fatty liver disease adversely affects the glycemic control afforded by sitagliptin. | 2012 | Details |
| A25137 | 22149719 | Ann Med | Mapping body fat distribution: a key step towards the identification of the vulnerable patient? | 2011 | Details |
| A25146 | 22139492 | Nihon Shokakibyo Gakkai Zasshi | [A case of non-alcoholic fatty liver disease (NAFLD) aggravated after treatment with raloxifene]. | 2011 | Details |
| A25155 | 22129639 | J Nutr Biochem | The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. | 2011 | Details |
| A25169 | 22118645 | Int J Exp Pathol | Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet. | 2011 | Details |
| A25177 | 22110479 | Exp Diabetes Res | Inhibition of aldose reductase activates hepatic peroxisome proliferator-activated receptor-α and ameliorates hepatosteatosis in diabetic db/db mice. | 2011 | Details |
| A25178 | 22110478 | Exp Diabetes Res | Role of transcription factor modifications in the pathogenesis of insulin resistance. | 2011 | Details |
| A25179 | 22110476 | Exp Diabetes Res | Diagnosis and evaluation of nonalcoholic fatty liver disease. | 2011 | Details |
| A25188 | 22105730 | Minerva Gastroenterol Dietol | Nonalcoholic fatty liver disease: the concept and confusion. | 2011 | Details |
| A25217 | 22087137 | Hepat Mon | HCC, diet and metabolic factors: Diet and HCC. | 2011 | Details |
| A25221 | 22082482 | Curr Mol Med | The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease. | 2012 | Details |
| A25230 | 22074433 | Curr Pharm Des | Liver enzymes: potential cardiovascular risk markers? | 2011 | Details |
| A25255 | 22030814 | Acta Cir Bras | Fructose and NAFLD: metabolic implications and models of induction in rats. | 2011 | Details |
| A25265 | 22024606 | Med Princ Pract | Nonalcoholic fatty liver disease of two ethnic groups in Kuwait: comparison of prevalence and risk factors. | 2011 | Details |
| A25267 | 22024083 | Hepatogastroenterology | Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitus. | 2012 | Details |
| A25277 | 22014765 | Diabetes Res Clin Pract | Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis C. | 2011 | Details |
| A25287 | 21994008 | Hepatology | Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. | 2012 | Details |
| A25292 | 21989716 | Mol Cell Biochem | Ω3-Polyunsaturated fatty acids prevent lipoperoxidation, modulate antioxidant enzymes, and reduce lipid content but do not alter glycogen metabolism in the livers of diabetic rats fed on a high fat thermolyzed diet. | 2011 | Details |
| A25293 | 21988593 | Diabet Med | Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities. | 2012 | Details |
| A25305 | 21983273 | Biochim Biophys Acta | Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice. | 2011 | Details |
| A25312 | 21967816 | Am J Pathol | Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in A×B mice. | 2011 | Details |
| A25313 | 21964711 | Front Med | Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological abnormalities. | 2011 | Details |
| A25315 | 21963564 | Biochim Biophys Acta | Liver triacylglycerol lipases. | 2011 | Details |
| A25317 | 21962038 | BMC Public Health | Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. | 2011 | Details |
| A25318 | 21960993 | Exp Diabetes Res | Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25323 | 21956711 | Diabetologia | Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial. | 2011 | Details |
| A25326 | 21953798 | Diabetes Care | Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the Bogalusa Heart Study. | 2011 | Details |
| A25332 | 21952702 | Arq Gastroenterol | Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis. | 2012 | Details |
| A25337 | 21948570 | Turk J Gastroenterol | A new risk factor for the development of non-alcoholic fatty liver disease: HLA complex genes. | 2011 | Details |
| A25360 | 21929649 | J Gastroenterol Hepatol | Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. | 2012 | Details |
| A25364 | 21917086 | Hepatol Res | Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic? | 2011 | Details |
| A25374 | 21910085 | Adv Exp Med Biol | Glycosphingolipids and insulin resistance. | 2011 | Details |
| A25375 | 21910084 | Adv Exp Med Biol | Sphingolipids and hepatic steatosis. | 2011 | Details |
| A25376 | 21910083 | Adv Exp Med Biol | Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity. | 2011 | Details |
| A25393 | 21894292 | Med Ultrason | Association between fatty liver disease and carotid atherosclerosis in patients with uncomplicated type 2 diabetes mellitus. | 2011 | Details |
| A25398 | 21892559 | Nutr Hosp | Molecular mechanisms of steatosis in nonalcoholic fatty liver disease. | 2012 | Details |
| A25403 | 21886908 | Sci Pharm | Type 2 Diabetes Mellitus-Induced Hyperglycemia in Patients with NAFLD and Normal LFTs: Relationship to Lipid Profile, Oxidative Stress and Pro-Inflammatory Cytokines. | 2011 | Details |
| A25409 | 21883436 | Diabet Med | Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver. | 2012 | Details |
| A25426 | 21862168 | Diabetes Res Clin Pract | Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes. | 2011 | Details |
| A25438 | 21841322 | Intern Med | Serum dehydroepiandrosterone sulphate levels in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25466 | 21801491 | Redox Rep | Unbalanced oxidant-antioxidant status and its effects in pediatric diseases. | 2011 | Details |
| A25472 | 21795844 | J Endocrinol Invest | Increased prevalence of cardiovascular disease in Type 1 diabetic patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25480 | 21787451 | Br J Nutr | Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice. | 2011 | Details |
| A25484 | 21778625 | Nihon Ronen Igakkai Zasshi | [Organs related to glucose metabolism and aging in animal models]. | 2011 | Details |
| A25491 | 21770819 | Scand J Gastroenterol | Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis. | 2011 | Details |
| A25501 | 21764273 | Nutr Metab Cardiovasc Dis | Obesity and metabolic syndrome: potential benefit from specific nutritional components. | 2011 | Details |
| A25504 | 21761549 | Liver Transpl | Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens? | 2011 | Details |
| A25505 | 21760546 | J Pediatr Gastroenterol Nutr | Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children. | 2012 | Details |
| A25507 | 21756849 | J Hepatol | The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. | 2011 | Details |
| A25512 | 21751587 | J Assoc Physicians India | Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. | 2011 | Details |
| A25519 | 21748768 | Hepatology | Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis. | 2011 | Details |
| A25523 | 21745307 | Liver Int | PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes. | 2011 | Details |
| A25533 | 21740407 | Br J Pharmacol | Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis. | 2012 | Details |
| A25538 | 21735081 | Dig Dis Sci | Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes. | 2011 | Details |
| A25549 | 21725988 | Hepatology | Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population. | 2011 | Details |
| A25569 | 21703998 | Gastroenterology | Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. | 2011 | Details |
| A25581 | 21694801 | Therap Adv Gastroenterol | Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25585 | 21688564 | Rev Med Chir Soc Med Nat Iasi | [The influence and prevalence of nonalcoholic steatohepatitis in chronic hepatitis B]. | 2011 | Details |
| A25594 | 21674556 | Hepatology | Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. | 2011 | Details |
| A25600 | 21665509 | Diabetes Metab | Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitus. | 2011 | Details |
| A25616 | 21641054 | Int J Cardiol | Visceral abdominal adipose tissue and coronary atherosclerosis in asymptomatic diabetics. | 2011 | Details |
| A25624 | 21633178 | J Clin Invest | The role of lipid droplets in metabolic disease in rodents and humans. | 2011 | Details |
| A25641 | 21612059 | Vnitr Lek | [Steatosis and steatohepatitis in diabetic patient]. | 2011 | Details |
| A25642 | 21604917 | Ann Med | The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis. | 2011 | Details |
| A25647 | 21599535 | Crit Rev Biochem Mol Biol | Insulin signaling to hepatic lipid metabolism in health and disease. | 2011 | Details |
| A25649 | 21596453 | Diabetes Res Clin Pract | Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently. | 2011 | Details |
| A25650 | 21595271 | Nihon Rinsho | [Attenuation of fatty accumulation in hepatocyte by incretin--expectation of novel medicine for treatment of NASH]. | 2011 | Details |
| A25653 | 21587068 | Curr Opin Clin Nutr Metab Care | The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease. | 2011 | Details |
| A25656 | 21576832 | Intern Med | The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25660 | 21569626 | Lipids Health Dis | Exercise and spirulina control non-alcoholic hepatic steatosis and lipid profile in diabetic Wistar rats. | 2011 | Details |
| A25664 | 21565756 | Orv Hetil | [Clinical correlations of chronic hepatitis C, diabetes mellitus and steatohepatitis]. | 2011 | Details |
| A25665 | 21565479 | Nutr Metab Cardiovasc Dis | Management of metabolic syndrome in children and adolescents. | 2011 | Details |
| A25666 | 21564529 | Am J Transplant | Should metformin be our antiglycemic agent of choice post-transplantation? | 2011 | Details |
| A25671 | 21562784 | Dig Dis Sci | Fatty liver is associated with recurrent bacterial infections independent of metabolic syndrome. | 2011 | Details |
| A25681 | 21556019 | Nat Rev Endocrinol | Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. | 2011 | Details |
| A25682 | 21549692 | Eur J Pharmacol | Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome. | 2011 | Details |
| A25684 | 21547049 | J Ayurveda Integr Med | A study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease. | 2010 | Details |
| A25699 | 21525818 | Med Sci Monit | SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. | 2011 | Details |
| A25702 | 21521338 | Clin Endocrinol (Oxf) | Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. | 2011 | Details |
| A25712 | 21518594 | Chin Med J (Engl) | Association between non-alcoholic fatty liver disease and coronary artery disease severity. | 2011 | Details |
| A25718 | 21510837 | Curr Top Med Chem | A new perspective of cannabinoid 1 receptor antagonists: approaches toward peripheral CB1R blockers without crossing the blood-brain barrier. | 2011 | Details |
| A25728 | 21502672 | Ann Hepatol | Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community. | 2011 | Details |
| A25754 | 21478462 | Diabetes Care | Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. | 2011 | Details |
| A25786 | 21457446 | Liver Int | Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. | 2011 | Details |
| A25787 | 21457442 | Liver Int | Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. | 2011 | Details |
| A25791 | 21452138 | Ther Umsch | [Non-alcoholic steatohepatitis - from NAFLD to MAFLD]. | 2011 | Details |
| A25808 | 21439567 | Atherosclerosis | Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease. | 2011 | Details |
| A25809 | 21438811 | Expert Rev Cardiovasc Ther | Hepatic steatosis and Type 2 diabetes: current and future treatment considerations. | 2011 | Details |
| A25814 | 21431854 | Curr Diab Rep | Why does NAFLD predict type 2 diabetes? | 2011 | Details |
| A25821 | 21427524 | J Endocrinol Invest | Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence? | 2011 | Details |
| A25825 | 21425426 | Diabetes Metab Res Rev | Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do. | 2011 | Details |
| A25835 | 21412813 | Hepatology | Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway. | 2011 | Details |
| A25836 | 21412139 | Am J Med Sci | Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic. | 2011 | Details |